Education
About Us
Working with TipRanks
Follow Us
BrightPath Biotherapeutics Co.Ltd. (JP:4594)
:4594
4594 Stock Chart & Stats
¥67.00
¥1.00(2.27%)
At close: 4:00 PM EST
¥67.00
¥1.00(2.27%)
Day’s Range― - ―
52-Week Range¥32.00 - ¥114.00
Previous CloseN/A
Volume188.00K
Average Volume (3M)2.78M
Market Cap
¥7.24B
Enterprise Value¥3.87B
Total Cash (Recent Filing)¥1.30B
Total Debt (Recent Filing)¥500.00M
Price to Earnings (P/E)―
Beta1.19
Next Earnings
Nov 14, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.59
Shares Outstanding111,391,300
10 Day Avg. Volume4,086,650
30 Day Avg. Volume2,782,203
Financial Highlights & Ratios
PEG Ratio0.14
Price to Book (P/B)3.88
Price to Sales (P/S)3165.29
P/FCF Ratio-2.87
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
4594 FAQ
What was BrightPath Biotherapeutics Co.Ltd.’s price range in the past 12 months?
BrightPath Biotherapeutics Co.Ltd. lowest stock price was ¥32.00 and its highest was ¥114.00 in the past 12 months.
What is BrightPath Biotherapeutics Co.Ltd.’s market cap?
BrightPath Biotherapeutics Co.Ltd.’s market cap is ¥7.24B.
When is BrightPath Biotherapeutics Co.Ltd.’s upcoming earnings report date?
BrightPath Biotherapeutics Co.Ltd.’s upcoming earnings report date is Nov 14, 2025 which is in 20 days.
How were BrightPath Biotherapeutics Co.Ltd.’s earnings last quarter?
BrightPath Biotherapeutics Co.Ltd. released its earnings results on Aug 08, 2025. The company reported -¥2.59 earnings per share for the quarter, missing the consensus estimate of N/A by -¥2.59.
Is BrightPath Biotherapeutics Co.Ltd. overvalued?
According to Wall Street analysts BrightPath Biotherapeutics Co.Ltd.’s price is currently Overvalued.
Does BrightPath Biotherapeutics Co.Ltd. pay dividends?
BrightPath Biotherapeutics Co.Ltd. does not currently pay dividends.
What is BrightPath Biotherapeutics Co.Ltd.’s EPS estimate?
BrightPath Biotherapeutics Co.Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BrightPath Biotherapeutics Co.Ltd. have?
BrightPath Biotherapeutics Co.Ltd. has 111,391,300 shares outstanding.
What happened to BrightPath Biotherapeutics Co.Ltd.’s price movement after its last earnings report?
BrightPath Biotherapeutics Co.Ltd. reported an EPS of -¥2.59 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.899%.
Which hedge fund is a major shareholder of BrightPath Biotherapeutics Co.Ltd.?
Currently, no hedge funds are holding shares in JP:4594
Company Description
BrightPath Biotherapeutics Co.Ltd.
BrightPath Biotherapeutics Co. Ltd. (4594) is a biotechnology company focused on the research, development, and commercialization of innovative biotherapeutic products. Operating primarily in the pharmaceutical sector, BrightPath specializes in the development of novel treatments for various diseases, with an emphasis on oncology and autoimmune disorders. The company leverages advanced biotechnological methods to create targeted therapies that aim to improve patient outcomes and quality of life.
Technical Analysis
Trans Genic Inc.
―
Immuno-Biological Laboratories Co., Ltd.
―
Ribomic, Inc.
―
Delta-Fly Pharma, Inc.
―
FunPep Company Limited
―